SORRENTO THERAPEUTICS AND VIRALCLEAR ENTER INTO AGREEMENT TO EXPLORE THE COMBINATION OF ANTIBODY AND ANTIVIRAL ASSETS AGAINST COVID-19

Ads

You May Also Like

Shire and NanoMedSyn Enter Into Research Agreement for Potential Lysosomal Storage Disorder Treatment

 Shire and NanoMedSyn Enter Into Research Agreement for Potential Lysosomal Storage Disorder Treatment  Research ...

Delcath Announces Satisfaction of 2016 Convertible Note

NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional ...